title: Phase II study of 4'epirubicin in advanced squamous cell oesophageal cancer.
authors.forename: M
authors.initials: M
authors.lastname: Spielmann
authors.forename: D
authors.initials: D
authors.lastname: Gandia
authors.forename: K
authors.initials: K
authors.lastname: Fizazi
authors.forename: T
authors.initials: T
authors.lastname: Guillot
authors.forename: E
authors.initials: E
authors.lastname: Cvitkovic
authors.forename: L
authors.initials: L
authors.lastname: Kayitalire
authors.forename: T
authors.initials: T
authors.lastname: Girinsky
authors.forename: D
authors.initials: D
authors.lastname: Elias
authors.forename: P
authors.initials: P
authors.lastname: Rougier
authors.forename: J
authors.initials: J
authors.lastname: Kac
mesh_terms: D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy*; D015251:Epirubicin / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D015251:Epirubicin